Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
|Molecular Profile||Indication/Tumor Type||Response Type||Relevant Treatment Approaches||Therapy Name||Approval Status||Evidence Type||Efficacy Evidence||References|
|KIT V559D KIT T670I||Advanced Solid Tumor||sensitive||Sunitinib||Preclinical - Cell culture||Actionable||In a preclinical study, Sutent (sunitinib) inhibited proliferation of transformed cells expressing KIT T670I and KIT V559D in culture (PMID: 31205508).||31205508|
|KIT V559D KIT T670I||Advanced Solid Tumor||sensitive||Sunitinib||Preclinical - Cell culture||Actionable||In a preclinical study, transformed cells co-expressing KIT V559D and KIT T670I were sensitive to treatment with Sutent (sunitinib) in culture, demonstrating decreased cell proliferation (PMID: 24205792).||24205792|
|Clinical Trial||Phase||Therapies||Title||Recruitment Status|